This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Cannon, C. P. Articles by Valcke, C. P. Search for Related Content PubMed PubMed Citation Articles by Cannon, C. P. Articles by Valcke, C. P. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Blood Thinners Hazardous Substances DB HEPARIN Related Collections Cardiovascular Pharmacology Anticoagulant mechanisms Coagulation and fibronolysis

(Circulation. 1999;99:751-756.)
© 1999 American Heart Association, Inc.

Clinical Investigation and Reports

Automated Heparin-Delivery System to Control Activated Partial Thromboplastin Time

Evaluation in Normal Volunteers

Christopher P. Cannon, MD; Jasper Dingemanse, PhD; Cornelis H. Kleinbloesem, PhD; Thomas Jannett, PhD; Kenneth M. Curry, BS; Christian P. Valcke, PhD

From the Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass (C.P.C.); Clin-Pharma Research Ltd, Birsfelden, Switzerland (J.D., C.H.K.); University of Alabama, Birmingham, Ala (T.J.); and Gensia Automedics, Inc, San Diego, Calif (K.C., C.P.V.).

Correspondence to Christopher P. Cannon, MD, Cardiovascular Division, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115. E-mail ccannon{at}rics.bwh.harvard.edu

Background—Unfractionated heparin is used widely; however, control of the level of anticoagulation remains its greatest problem, with fewer than 35% of patients having activated partial thromboplastin times (aPTTs) within a range of 55 to 85 seconds in recent trials.

Methods and Results—We developed and tested a prototype of an automated heparin control system (AutoHep) in which a computer-based titration algorithm adjusted the heparin infusion to reach a target aPTT. In 1 study, 12 healthy male subjects received an intravenous infusion of heparin with the rate determined by AutoHep and were randomized to receive an initial bolus or no bolus of heparin preceding the infusion. A second study evaluated the automated blood sampling system in 12 subjects. Of the 344 end-point aPTT measurements, 78% were within ±10 seconds of the target (prespecified primary end point), and 89% were within a ±15-second range. The time to achieve a target aPTT was 93 minutes without and 150 minutes with an initial heparin bolus. The total percentage of time within the target range ±15 seconds was 46 of 48 hours (96%). The automatic blood sampling system successfully obtained 96% of all scheduled samples.

Conclusions—These results suggest that the AutoHep system has the potential to significantly improve aPTT control of intravenous heparin compared with current clinical practice.

Key Words: heparin • coagulation • anticoagulants